J Nicholas Bodor - JoVE Visualize

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

American Journal of Preventive Medicine|August 12, 2009

Neighborhood food environments and Body Mass Index: the importance of in-store contentsDonald Rose, Paul L Hutchinson, J Nicholas Bodor, et al.

Journal of Thoracic Disease|July 14, 2026

Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case seriesJanani S Reisenauer, David M DiBardino, Gerard J Criner, et al.

Oncotarget|December 17, 2021

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Yasmine Baca, Joanne Xiu, et al.

International Journal of Cancer|May 26, 2020

Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumorsMohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.

Clinical Lung Cancer|June 22, 2025

Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase InhibitorsJ Nicholas Bodor, Jonathan Dowell, Joseph Treat, et al.

Clinical Lung Cancer|July 14, 2023

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.

Nature Communications|March 13, 2026

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human studyYonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist, et al.

Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

American Journal of Preventive Medicine|August 12, 2009

Neighborhood food environments and Body Mass Index: the importance of in-store contentsDonald Rose, Paul L Hutchinson, J Nicholas Bodor, et al.

Journal of Thoracic Disease|July 14, 2026

Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case seriesJanani S Reisenauer, David M DiBardino, Gerard J Criner, et al.

Oncotarget|December 17, 2021

Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomasRobert Hsu, Yasmine Baca, Joanne Xiu, et al.

International Journal of Cancer|May 26, 2020

Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumorsMohamed E Salem, J Nicholas Bodor, Alberto Puccini, et al.

Clinical Lung Cancer|June 22, 2025

Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase InhibitorsJ Nicholas Bodor, Jonathan Dowell, Joseph Treat, et al.

Clinical Lung Cancer|July 14, 2023

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never SmokedJ Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, et al.

Nature Communications|March 13, 2026

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human studyYonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist, et al.

Pageof 3